Elderly patients have a high risk of complications after stroke, such as infections or fever. This study aims to assess whether preventive treatment in the first four days of hospitalisation with ceftriaxone, paracetamol, and/or metoclopramide prevents the most common complications and reduce the risk of death or long-term disability compared to standard care alone.
Disease: Stroke
Study phase: III
ECRIN support role: Monitoring
Funding application support
Study/trial status: Recruitment/follow-up
Actual trial start date: 01/03/2016
Expected patient number: 3800 patients
Sponsor: Universitair Medisch Centrum Utrecht
Sponsor type: Academic
Principal investigator (PI): Bart van der Worp
Current participating countries: Estonia, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, United Kingdom